StonvexLoading…
StonvexCore line items from MATV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.99B | $1.98B | $2.03B | $1.64B |
Operating Income | $-384.40M | $6.30M | $-413.90M | $-40.20M |
Net Income | $-337.40M | $-48.70M | $-309.50M | $-6.60M |
EPS (Diluted) | $-6.19 | $-0.90 | $-5.69 | $-0.18 |
Total Assets | $2.05B | $2.45B | $2.64B | $3.67B |
Total Liabilities | $1.55B | $1.59B | $1.69B | $2.49B |
Cash & Equivalents | $84.20M | $94.30M | $120.20M | $101.10M |
Free Cash Flow OCF − CapEx | $93.80M | $39.80M | $40.60M | $156.60M |
Shares Outstanding | 54.68M | 54.34M | 54.21M | 54.93M |